Comorbidity, human papillomavirus infection and head and neck cancer survival in an ethnically diverse population

Oral Oncology

Volumn 49, Issue 9, 2013, Pages 911-917

  Ankola, Ashish A ^a   Smith, Richard V ^a   Burk, Robert D ^a   Prystowsky, Michael B ^a   Sarta, Catherine ^a   Schlecht, Nicolas F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

ACE 27; Comorbidity; Head and neck; Human papillomavirus; Oropharyngeal; Squamous cell carcinoma; Survival

Indexed keywords

ILLICIT DRUG; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ADULT COMORBIDITY EVALUATION 27; AGED; ANGINA PECTORIS; ARTICLE; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ABUSE; ETHNIC DIFFERENCE; FEMALE; HEAD AND NECK CARCINOMA; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; HYPERTENSION; LARYNX CARCINOMA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; MENTAL DISEASE; MOUTH CARCINOMA; NEOPLASM; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SOLID TUMOR; UNITED STATES; VEIN DISEASE; WART VIRUS;

ACE-27; COMORBIDITY; HEAD AND NECK; HUMAN PAPILLOMAVIRUS; OROPHARYNGEAL; SQUAMOUS CELL CARCINOMA; SURVIVAL;

COMORBIDITY; CULTURAL DIVERSITY; ETHNIC GROUPS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; SURVIVAL RATE;

EID: 84883133545     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.07.001     Document Type: Article

References (31)

1. J.F. Piccirillo, and A.R. Feinstein Clinical symptoms and comorbidity: significance for the prognostic classification of cancer Cancer 77 5 1996 834 842
2. V. Paleri, and R.G. Wight Applicability of the adult comorbidity evaluation - 27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study J Laryngol Otol 116 3 2002 200 205
3. J.F. Piccirillo Importance of comorbidity in head and neck cancer Laryngoscope 110 4 2000 593 602
4. S.H. Landis, I.A. El-Haririy, M.P. van Herk-Sukel, P. van den Haak, M.L. Janssen-Heijnen, and F.J. Penning-van Beest Prevalence and incidence of acute and chronic comorbidity in patients with squamous cell carcinoma of the head and neck Head Neck 34 2 2011 238 244
5. V.R. Paleri, R. Narayan, and R.G. Wight Descriptive study of the type and severity of decompensation caused by comorbidity in a population of patients with laryngeal squamous cancer J Laryngol Otol 118 7 2004 517 521
6. W. Derks, R.J. de Leeuw, and G.J. Hordijk Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival Curr Opin Otolaryngol Head Neck Surg 13 2 2005 92 96
7. J.F. Piccirillo, and A. Vlahiotis Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis Curr Oncol Rep 8 2 2006 123 129
8. P.A. Borggreven, D.J. Kulik, J.A. Langendijk, P. Doornaert, R. de Bree, and C.R. Leemans Severe comorbidity negatively influences prognosis in patients with oral and oropharyngeal cancer after surgical treatment with microvascular reconstruction Oral Oncol 41 4 2005 358 364
9. A. Homma, T. Sakashita, N. Oridate, F. Suzuki, S. Suzuki, and H. Hatakeyama Importance of comorbidity in hypopharyngeal cancer Head Neck 32 2 2010 148 153
10. V. Paleri, R.G. Wight, and G.R. Davies Impact of comorbidity on the outcome of laryngeal squamous cancer Head Neck 25 12 2003 1019 1026
11. J.F. Piccirillo, P.D. Lacy, A. Basu, and E.L. Spitznagel Development of a new head and neck cancer-specific comorbidity index Arch Otolaryngol Head Neck Surg 128 10 2002 1172 1179
12. J.F. Piccirillo, E.L. Spitznagel Jr., N. Vermani, I. Costas, and M. Schnitzler Comparison of comorbidity indices for patients with head and neck cancer Med Care 42 5 2004 482 486
13. J.F. Piccirillo, R.M. Tierney, I. Costas, L. Grove, and E.L. Spitznagel Prognostic importance of comorbidity in a hospital-based cancer registry JAMA 291 20 2004 2441 2447
14. M.B. Ferrier, E.B. Spuesens, S. Le Cessie, and R.J. Baatenburg de Jong Comorbidity as a major risk factor for mortality and complications in head and neck surgery Arch Otolaryngol Head Neck Surg 131 1 2005 27 32
15. F.R. Datema, M.B. Ferrier, M.P. van der Schroeff, and R.J. Baatenburg de Jong Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients Head Neck 32 6 2010 728 736
16. T.T. Peters, J.A. Langendijk, B.E. Plaat, J. Wedman, J.L. Roodenburg, and B.A. van Dijk Co-morbidity and treatment outcomes of elderly pharyngeal cancer patients: a matched control study Oral Oncol 47 12 2011 1159 1164
17. B. Singh, M. Bhaya, M. Zimbler, J. Stern, J.T. Roland, and R.M. Rosenfeld Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma Head Neck 20 1 1998 1 7
18. M. Morrow, J. Sylvester, and S. DesHarnais CoC and NCDB to examine approaches to classifying comorbidities: news from the commission on cancer J Am Coll Surg 11 2000 2 3
19. N.F. Schlecht, M. Brandwein-Gensler, G.J. Nuovo, M. Li, A. Dunne, and N. Kawachi A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer Mod Pathol 24 10 2011 1295 1305
20. S.S. Mukerji, S.A. Duffy, K.E. Fowler, M. Khan, D.L. Ronis, and J.E. Terrell Comorbidities in head and neck cancer: agreement between self-report and chart review Otolaryngol Head Neck Surg 136 4 2007 536 542
21. M.H. Kaplan, and A.R. Feinstein The importance of classifying initial co-morbidity in evaluation the outcome of diabetes mellitus J Chronic Dis 27 7-8 1974 387 404
22. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 1987 373 383
23. C.N. Klabunde, A.L. Potosky, J.M. Legler, and J.L. Warren Development of a comorbidity index using physician claims data J Clin Epidemiol 53 12 2000 1258 1267
24. D.H. Bang, J.F. Piccirillo, B. Littenberg, and A. Johnson The Adult Comorbidity Evaluation-27 (ACE-27) Test - a new comorbidity index for patients with cancer Proc Am Soc Clin Oncol 19 2000 1701
25. V. Paleri, R.G. Wight, C.E. Silver, M. Haigentz Jr., R.P. Takes, and P.J. Bradley Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice Oral Oncol 46 10 2010 712 719
26. T.J. Belbin, A. Bergman, M. Brandwein-Gensler, Q. Chen, G. Childs, and M. Garg Head and neck cancer: reduce and integrate for optimal outcome Cytogenet Genome Res 118 2-4 2007 92 109
27. S. Greenland, and J.M. Robins Identifiability, exchangeability and confounding revisited Epidemiol Perspect Innov 6 2009 4
28. New York State DOH [Internet]. Socio-Economic Status Indicators - Bronx County (November 2011). < http://www.health.ny.gov/statistics/chac/chai/docs/ ses-bronx.htm > July 10, 2012.
29. T.T. Peters, B.F. van der Laan, B.E. Plaat, J. Wedman, J.A. Langendijk, and G.B. Halmos The impact of comorbidity on treatment-related side effects in older patients with laryngeal cancer Oral Oncol 47 1 2011 56 61
30. M.A. O'Rorke, M.V. Ellison, L.J. Murray, M. Moran, J. James, and L.A. Anderson Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis Oral Oncol 48 12 2012 1191 1201
31. K.C. Yung, and J.F. Piccirillo The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer Arch Otolaryngol Head Neck Surg 134 10 2008 1045 1049